Preservation of fertility in patients with cancer [9]

New England Journal of Medicine

Volumn 360, Issue 25, 2009, Pages 2680-2683

  Lee, Stephanie J ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER PATIENT; EVIDENCE BASED PRACTICE; FERTILITY; HUMAN; LETTER; NEOPLASM; PRACTICE GUIDELINE; PRESERVATION; PRIORITY JOURNAL; ADULT; CHEMICALLY INDUCED DISORDER; CHILD; DRUG EFFECT; DRUG POTENTIATION; FEMALE; NOTE; PREMATURE OVARIAN FAILURE; MEDICAL SOCIETY; BREAST CANCER; CANCER CHEMOTHERAPY; CLINICAL TRIAL; HYPOGONADISM; OVARY INSUFFICIENCY; PATHOPHYSIOLOGY;

ANTINEOPLASTIC AGENT; GONADORELIN; GONADORELIN AGONIST;

ANTINEOPLASTIC AGENTS; CHILD; FEMALE; FERTILITY; GONADOTROPIN-RELEASING HORMONE; HUMANS; NEOPLASMS; OVARIAN FAILURE, PREMATURE; YOUNG ADULT; PRACTICE GUIDELINES AS TOPIC; SOCIETIES, MEDICAL;

EID: 67449158772     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc090614     Document Type: Letter

References (2)

1. Jeruss JS, Woodruff TK. Preservation of fertility in patients with cancer. N Engl J Med 2009;360:902-911
2. Lee SJ, Schover LR, Partridge AH, et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 2006;24:2917-2931 [Erratum, J Clin Oncol 2006;24:5790.] (Pubitemid 46655598)